Table 2.
Animal studies on the role of NDRG1
| Tumor type | Results | References |
|---|---|---|
| Colorectal cancer | ΔNDRG1: ↑tumor growth and liver metastasis | [31] |
| Colorectal cancer | ΔNDRG1: ↑invasion and metastasis | [32] |
| Colorectal cancer | ΔNDRG1: ↑tumor growth and tumor weight | [33] |
| Colorectal cancer | ΔNDRG1: ↑tumor growth and lung metastasis | [34] |
| Colorectal cancer | ΔNDRG1: ↑invasion and metastasis | [35] |
| Colorectal cancer | ΔNDRG1: ↑tumor growth | [36] |
| Breast cancer (TNBC) |
ΔYAP1(interaction with NDRG1): ↓tumor growth ↑↑ NDRG1: ↑ cell growth |
[4] |
| Breast cancer |
NDRG1 was co-expressed with and β-casein or MFP Up-regulation of NDRG1 resulted in the expansion of the differentiated area |
[2] |
| Gastric cancer | ΔNDRG1: ↑tumor weight and tumor volume | [28] |
| Nasopharyngeal cancer | ΔNDRG1: ↑cell proliferation | [54] |
| Non-small-cell lung cancer | ΔNDRG1: ↓tumor growth, tumor volume and angiogenesis | [48] |
| Osteosarcoma | Δ LncRNA NDRG1: ↓Tumor mass and volume and lung metastasis | [38] |
| Osteosarcoma |
ΔHER4 (interaction counterpart of NDRG1): ↓ tumor growth ↑↑NDRG1: ↑ tumor growth |
[40] |
| Prostate cancer |
↓ NDRG1: ↑ tumor growth Δ N-cadherin (interaction counterpart of NDRG1): ↓invasion and metastasis |
[14] |
| Prostate cancer | ↑↑ MLL5α (interaction counterpart of NDRG1): ↓tumor growth | [16] |
| Prostate cancer | Δ E6AP (interaction counterpart of NDRG1): ↓tumor growth | [21] |
| Clear cell renal cell carcinoma | Δ NDRG1: ↑tumor growth, ↑tumor volume and lung metastasis | [57] |